Synthesis of N2-(substituted benzyl)-3-(4-methylphenyl)indazoles as novel anti-angiogenic agents

被引:82
作者
Huang, LJ
Shih, ML
Chen, HS
Pan, SL
Teng, CM
Lee, FY
Kuo, SC [1 ]
机构
[1] China Med Univ, Grad Inst Pharmaceut Chem, Taichung, Taiwan
[2] Natl Taiwan Univ, Coll Med, Inst Pharmacol, Taipei, Taiwan
[3] Yung Shin Pharmacuet Ind Co Ltd, Taichung, Taiwan
关键词
anti-angiogenicagents; N-2-(substituted benzyl)-3-(4-methylphenyl)-indazoles;
D O I
10.1016/j.bmc.2005.08.032
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To search for novel compounds with potent anti-angiogenic activity, a series of N-1-(substituted benzyl)-3-(4-methylphenyl)-1H-indazoles (16, 18, 20, 22, 24, 26, 28, 30, 32) and N-2-(substituted benzyl)-3-(4-methylphenyl)-2H-indazoles (17, 19, 21, 23, 25, 27, 29, 31, and 33) were synthesized. The structures of these regioisomers were established by IR, UV, and NMR spectral data. 3-(4-Methylphenyl)-1H-indazole (6) and the N-2-substituted derivatives (17, 19, 21, 23, 25, 29, 31, 33) were evaluated for their anti-angiogenic activity. Most of them showed more prominent activity than ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate (YD-3). Among these tested compounds, 2-(4-chlorobenzyl)-3-(4-methylphenyl)-2H-indazole (19), 2-(4-methylbenzyl)-3-(4-methylphenyl)-2H-indazole (25), and 2-(4-methoxybenzyl)-3-(4-methylphenyl)-2H-indazole (31) showed significant anti-angiogenic activity and are worthy of further investigation. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:528 / 536
页数:9
相关论文
共 14 条
  • [1] BLATT AH, 1955, ORG SYNTH, V2, P135
  • [2] CHU V, 1969, Patent No. 2001923
  • [3] FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
  • [4] HORNING EC, 1957, ORG SYNTH, V3, P740
  • [5] Bevacizurnab in combination with fluorouracil and leucovorin: An active regimen for first-line metastatic colorectal cancer
    Hurwitz, HI
    Fehrenbacher, L
    Hainsworth, JD
    Heim, W
    Berlin, J
    Holmgren, E
    Hambleton, J
    Novotny, WF
    Kabbinavar, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) : 3502 - 3508
  • [6] CULTURE OF HUMAN ENDOTHELIAL CELLS DERIVED FROM UMBILICAL VEINS - IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGICAL CRITERIA
    JAFFE, EA
    NACHMAN, RL
    BECKER, CG
    MINICK, CR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (11) : 2745 - 2756
  • [7] MATSUDE H, 1973, Patent No. 2263879
  • [8] MCCRAE W, 1973, BASIC ORGANIC REACTI, P80
  • [9] NORMAN R, 1967, ORGANIC SYNTHESIS, V4
  • [10] YC-1[3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models
    Pan, SL
    Guh, JH
    Peng, CY
    Wang, SW
    Chang, YL
    Cheng, FC
    Chang, JH
    Kuo, SC
    Lee, FY
    Teng, CM
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 314 (01) : 35 - 42